This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Genazzani, A. R. Articles by Luisi, M. Search for Related Content PubMed PubMed Citation Articles by Genazzani, A. R. Articles by Luisi, M.

Circulating Levels of Allopregnanolone in Humans: Gender, Age, and Endocrine Influences

Department of Reproductive Medicine and Child Development, Section of Gynecology and Obstetrics, University of Pisa, Pisa; the Department of Surgical Sciences, Chair of Obstetrics and Gynecology, University of Udine (F.P.), Udine; Endocrine Unit of the Italian Research Council, CNR (E.C., M.L.), Pisa; the Department of Obstetrics and Gynecology, University of Pavia (R.E.N.), Pavia; and the Department of Obstetrics and Gynecology, University of Catania (M.P.), Catania, Italy; and the Department of Psychiatry, Veterans Administration Hospital (R.H.P.), San Diego, California 92161

Address all correspondence and requests for reprints to: Prof. A. R. Genazzani, Department of Reproductive Medicine and Child Development, Section of Gynecology and Obstetrics, University of Pisa, Via Roma 35, 56100 Pisa, Italy.

Allopregnanolone is a neuroactive steroid involved in modulating behavioral functions, stress, and neuroendocrine axes in rats. Changes in plasma allopregnanolone levels throughout the menstrual cycle have been reported in healthy women, but there exists no information on the possible gender or age-related changes or on the source(s) of circulating allopregnanolone. The aim of the present study was to assess serum allopregnanolone concentrations according to gender, menstrual cycle, age, and menopause in normal men and women; serum progesterone (P) and dehydroepiandrosterone (DHEA) levels were evaluated in the same specimens. In addition, the possible source of circulating allopregnanolone in fertile women was investigated by using stimulatory and inhibitory endocrine tests acting on the ovary and/or adrenal cortex.

The present study included 189 fertile women, 112 postmenopausal women, and 46 men. Serum steroid levels were determined after extraction, using specific RIAs. Allopregnanolone levels in fertile women in the follicular phase were similar to those in age-matched men; no significant difference was found between fertile women in the follicular phase and postmenopausal women. The highest levels were found in fertile women during the luteal phase (P < 0.01). An age-related decrease was observed in men (P < 0.01), but not in women. P and DHEA levels were significantly higher in women than in men and were higher in fertile women than in postmenopausal women (P < 0.01). Both P and DHEA showed an age-related decrease in men and women (P < 0.01).

Serum allopregnanolone and P, but not DHEA, significantly increased in response to a GnRH test, whereas corticotropin-releasing factor and ACTH tests elicited a significant increase in allopregnanolone, P, and DHEA levels (P < 0.01). The suppression of adrenal steroidogenesis by dexamethasone markedly reduced both allopregnanolone and DHEA serum levels (P < 0.01).

In conclusion, the present study demonstrated that although men show an age-related decrease, serum allopregnanolone levels in women do not change with age and correlate with P levels during the menstrual cycle and in response to endocrine tests. Ovary and adrenal cortex may be major sources of circulating allopregnanolone in fertile women.

This article has been cited by other articles:

				K. A. Grant, C. M. Helms, L. S. M. Rogers, and R. H. Purdy Neuroactive Steroid Stereospecificity of Ethanol-Like Discriminative Stimulus Effects in Monkeys J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 354 - 361. [Abstract] [Full Text] [PDF]

				R. Kancheva, M. Hill, D. Cibula, H. Vcelakova, L. Kancheva, J. Vrbikova, T. Fait, A. Parizek, and L. Starka Relationships of circulating pregnanolone isomers and their polar conjugates to the status of sex, menstrual cycle, and pregnancy J. Endocrinol., October 1, 2007; 195(1): 67 - 78. [Abstract] [Full Text] [PDF]

				M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System Endocr. Rev., June 1, 2007; 28(4): 387 - 439. [Abstract] [Full Text] [PDF]

				A. R. Genazzani, N. Pluchino, S. Luisi, and M. Luisi Estrogen, cognition and female ageing Hum. Reprod. Update, March 1, 2007; 13(2): 175 - 187. [Abstract] [Full Text] [PDF]

				H. Havlikova, M. Hill, L. Kancheva, J. Vrbikova, V. Pouzar, I. Cerny, R. Kancheva, and L. Starka Serum Profiles of Free and Conjugated Neuroactive Pregnanolone Isomers in Nonpregnant Women of Fertile Age J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3092 - 3099. [Abstract] [Full Text] [PDF]

				M. Zitzmann, M. Erren, A. Kamischke, M. Simoni, and E. Nieschlag Endogenous Progesterone and the Exogenous Progestin Norethisterone Enanthate Are Associated with a Proinflammatory Profile in Healthy Men J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6603 - 6608. [Abstract] [Full Text] [PDF]

				I. Charalampopoulos, E. Dermitzaki, L. Vardouli, C. Tsatsanis, C. Stournaras, A. N. Margioris, and A. Gravanis Dehydroepiandrosterone Sulfate and Allopregnanolone Directly Stimulate Catecholamine Production via Induction of Tyrosine Hydroxylase and Secretion by Affecting Actin Polymerization Endocrinology, August 1, 2005; 146(8): 3309 - 3318. [Abstract] [Full Text] [PDF]

				J. M. Wang, P. B. Johnston, B. G. Ball, and R. D. Brinton The Neurosteroid Allopregnanolone Promotes Proliferation of Rodent and Human Neural Progenitor Cells and Regulates Cell-Cycle Gene and Protein Expression J. Neurosci., May 11, 2005; 25(19): 4706 - 4718. [Abstract] [Full Text] [PDF]

				E. Sanna, G. Talani, F. Busonero, M. G. Pisu, R. H. Purdy, M. Serra, and G. Biggio Brain Steroidogenesis Mediates Ethanol Modulation of GABAA Receptor Activity in Rat Hippocampus J. Neurosci., July 21, 2004; 24(29): 6521 - 6530. [Abstract] [Full Text] [PDF]

				I. Charalampopoulos, C. Tsatsanis, E. Dermitzaki, V.-I. Alexaki, E. Castanas, A. N. Margioris, and A. Gravanis Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins PNAS, May 25, 2004; 101(21): 8209 - 8214. [Abstract] [Full Text] [PDF]

				L. Iughetti, B. Predieri, L. Cobellis, S. Luisi, M. Luisi, S. Forese, F. Petraglia, and S. Bernasconi High Serum Allopregnanolone Levels in Girls with Precocious Puberty J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2262 - 2265. [Abstract] [Full Text] [PDF]

				J. A. Sim, M. J. Skynner, and A. E. Herbison Direct Regulation of Postnatal GnRH Neurons by the Progesterone Derivative Allopregnanolone in the Mouse Endocrinology, October 1, 2001; 142(10): 4448 - 4453. [Abstract] [Full Text] [PDF]

				M. Altemus, L. S. Redwine, Y.-M. Leong, C. A. Frye, S. W. Porges, and C. S. Carter Responses to Laboratory Psychosocial Stress in Postpartum Women Psychosom Med, September 1, 2001; 63(5): 814 - 821. [Abstract] [Full Text] [PDF]

				B. E. P. Murphy Allopregnanolone Assays J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1425 - 1425. [Full Text]

				F. Petraglia Author's Response: Allopregnanolone Assays J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1425a - 1425. [Full Text]

				P. Monteleone, M. Luisi, B. Colurcio, E. Casarosa, P. Monteleone, R. Ioime, A. R. Genazzani, and M. Maj Plasma Levels of Neuroactive Steroids Are Increased in Untreated Women With Anorexia Nervosa or Bulimia Nervosa Psychosom Med, January 1, 2001; 63(1): 62 - 68. [Abstract] [Full Text] [PDF]

				S. Luisi, F. Petraglia, C. Benedetto, R. E. Nappi, F. Bernardi, M. Fadalti, F. M. Reis, M. Luisi, and A. R. Genazzani Serum Allopregnanolone Levels in Pregnant Women: Changes during Pregnancy, at Delivery, and in Hypertensive Patients J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2429 - 2433. [Abstract] [Full Text]